Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine vs Remifentanil Analgesic Sedation and Respiratory Mechanics in Mechanically Ventilated ARDS Patients
ChiCTR2300070733Phase 4Recruiting
- Sponsor
- Tangdu Hospital
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in acute respiratory distress syndrome (ARDS) (2 arms), sponsored by Tangdu Hospital. Primary endpoints: airway resistance, static lung compliance and 2 more. Started Feb 2023; status: recruiting.
02
Drugs
esketamine
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on ChiCTR2300070733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070733.